(furan-2-yl)-pyran-2-one derivatives were synthesized and evaluated for their in vivo
antihyperglycemic activity in sucrose-loaded streptozotocin-induced diabetic rat model. Five
of the test compounds showed significant lowering of plasma glucose level in STZ-S model.